title: Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors.
abstract: Like a number of neuropeptides, galanin can alter neural activity in brain areas that are important for both stress-related behaviors and responses to drugs of abuse. Accordingly, drugs that target galanin receptors can alter behavioral responses to drugs of abuse and can modulate stress-related behaviors. Stress and drug-related behaviors are interrelated: stress can promote drug-seeking, and drug exposure and withdrawal can increase activity in brain circuits involved in the stress response. We review here what is known about the ability of galanin and galanin receptors to alter neuronal activity, and we discuss potential mechanisms that may underlie the effects of galanin on behaviors involved in responses to stress and addictive drugs. Understanding the mechanisms underlying galanin's effects on neuronal function in brain regions related to stress and addiction may be useful in developing novel therapeutics for the treatment of stress- and addiction-related disorders.
authors.affiliation: Division of Molecular Psychiatry, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Yale University School of Medicine, New Haven, CT, USA. marina.picciotto@yale.edu
authors.forename: Marina R
authors.initials: MR
authors.lastname: Picciotto
authors.forename: Christian
authors.initials: C
authors.lastname: Brabant
authors.forename: Emily B
authors.initials: EB
authors.lastname: Einstein
authors.forename: Helen M
authors.initials: HM
authors.lastname: Kamens
authors.forename: Nichole M
authors.initials: NM
authors.lastname: Neugebauer
mesh_terms: D000818:Animals; D015306:Biogenic Monoamines / Q000502:physiology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D019004:Galanin / Q000502:physiology*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism / Q000503:physiopathology*; D008032:Limbic System / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D044088:Receptors, Galanin / Q000187:drug effects / Q000378:metabolism; D013315:Stress, Psychological / Q000378:metabolism / Q000503:physiopathology*; D013375:Substance Withdrawal Syndrome / Q000378:metabolism / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000378:metabolism / Q000503:physiopathology*
chemical_list: D015306:Biogenic Monoamines; D044088:Receptors, Galanin; D019004:Galanin
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):354-9
references.pmid: 14701907
references.citation: Cell Mol Life Sci. 2008 Jun;65(12):1854-63
references.pmid: 18500640
references.citation: J Neurosci. 1998 May 15;18(10):3489-500
references.pmid: 9570780
references.citation: Eur J Pharmacol. 2008 Jan 14;578(2-3):185-93
references.pmid: 17945210
references.citation: Neurochem Res. 1992 May;17(5):401-7
references.pmid: 1356241
references.citation: Cell Mol Life Sci. 2008 Jun;65(12):1796-805
references.pmid: 18500647
references.citation: Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8047-51
references.pmid: 7520174
references.citation: Eur J Pharmacol. 1989 May 19;164(2):373-6
references.pmid: 2474450
references.citation: Psychopharmacology (Berl). 2009 May;204(1):95-102
references.pmid: 19099295
references.citation: J Comp Neurol. 1993 Aug 22;334(4):603-17
references.pmid: 8408768
references.citation: Neuropsychopharmacology. 2000 Aug;23(2):127-37
references.pmid: 10882839
references.citation: Genes Brain Behav. 2008 Oct;7(7):720-9
references.pmid: 18518925
references.citation: J Neurophysiol. 2006 Jul;96(1):154-64
references.pmid: 16611841
references.citation: Eur J Pharmacol. 1986 Mar 11;122(1):159-60
references.pmid: 2420618
references.citation: Biol Psychiatry. 2006 Jun 15;59(12):1151-9
references.pmid: 16566899
references.citation: Neuropharmacology. 2009;56 Suppl 1:122-32
references.pmid: 18675281
references.citation: Brain Res. 1999 Mar 20;822(1-2):200-9
references.pmid: 10082897
references.citation: Neuropsychopharmacology. 2008 Jul;33(8):1779-97
references.pmid: 17928814
references.citation: Brain Res. 1999 Jun 12;831(1-2):33-42
references.pmid: 10411981
references.citation: J Neurochem. 1998 Dec;71(6):2239-51
references.pmid: 9832121
references.citation: Pharmacol Toxicol. 1990;66 Suppl 3:100-11
references.pmid: 2179926
references.citation: Eur J Neurosci. 2008 Jun;27(11):2973-84
references.pmid: 18588537
references.citation: FEBS Lett. 1983 Nov 28;164(1):124-8
references.pmid: 6197320
references.citation: Neuroendocrinology. 2000 Jan;71(1):60-7
references.pmid: 10644900
references.citation: Int J Mol Med. 2007 Apr;19(4):639-47
references.pmid: 17334639
references.citation: J Biol Chem. 1998 Sep 4;273(36):23321-6
references.pmid: 9722565
references.citation: Neurosci Biobehav Rev. 1989 Summer-Fall;13(2-3):129-33
references.pmid: 2573023
references.citation: Cell Mol Life Sci. 2008 Jun;65(12):1813-9
references.pmid: 18500645
references.citation: Neuroscience. 1995 Feb;64(4):861-74
references.pmid: 7538638
references.citation: Neurosci Biobehav Rev. 2008;32(3):508-24
references.pmid: 18023876
references.citation: Physiol Behav. 2003 Jun;79(1):103-11
references.pmid: 12818715
references.citation: J Comp Neurol. 1998 Mar 9;392(2):227-51
references.pmid: 9512271
references.citation: Neuroscience. 2009 Jun 2;160(4):837-46
references.pmid: 19272414
references.citation: Brain Res. 1999 Nov 27;848(1-2):174-82
references.pmid: 10612709
references.citation: Peptides. 1989 Mar-Apr;10(2):453-7
references.pmid: 2474156
references.citation: J Neurophysiol. 2006 May;95(5):3228-34
references.pmid: 16481456
references.citation: J Neurosci. 1997 Aug 15;17(16):6048-56
references.pmid: 9236216
references.citation: Alcohol. 2004 Jun;33(2):91-7
references.pmid: 15528006
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1214-24
references.pmid: 16226365
references.citation: Genes Brain Behav. 2007 Jul;6(5):473-81
references.pmid: 17083333
references.citation: Cell Mol Life Sci. 2008 Jun;65(12):1842-53
references.pmid: 18500641
references.citation: J Neurosci. 2003 Jan 15;23(2):416-21
references.pmid: 12533601
references.citation: Endocrinology. 1991 Feb;128(2):917-22
references.pmid: 1703485
references.citation: Neuroscience. 2002;112(1):173-82
references.pmid: 12044482
references.citation: Neuron. 2008 Jul 10;59(1):11-34
references.pmid: 18614026
references.citation: Brain Res. 1993 Mar 5;605(1):128-38
references.pmid: 8467382
references.citation: Amino Acids. 2006 Oct;31(3):231-9
references.pmid: 16733616
references.citation: Am J Physiol. 1992 Jul;263(1 Pt 1):E8-16
references.pmid: 1379000
references.citation: Proc Natl Acad Sci U S A. 1987 Oct;84(20):7339-43
references.pmid: 2444980
references.citation: Endocrinology. 2007 Dec;148(12):5780-93
references.pmid: 17823252
references.citation: J Neural Transm Gen Sect. 1993;93(1):11-25
references.pmid: 8373553
references.citation: Eur J Neurosci. 2006 Jun;23(11):2937-46
references.pmid: 16819983
references.citation: J Neurochem. 2006 Feb;96(4):1160-8
references.pmid: 16417577
references.citation: Neuropharmacology. 2009;56 Suppl 1:32-43
references.pmid: 18725235
references.citation: Br J Pharmacol. 1997 Jul;121(6):1180-6
references.pmid: 9249255
references.citation: J Neurosci. 1995 May;15(5 Pt 1):3390-9
references.pmid: 7751918
references.citation: Alcohol Clin Exp Res. 2007 Nov;31(11):1858-65
references.pmid: 17850217
references.citation: Pharmacol Biochem Behav. 2000 May;66(1):65-72
references.pmid: 10837844
references.citation: Neuroendocrinology. 2003 Aug;78(2):105-17
references.pmid: 12915763
references.citation: Neurosci Lett. 2006 Sep 11;405(1-2):111-5
references.pmid: 16854525
references.citation: J Neurochem. 2005 Jun;93(5):1168-76
references.pmid: 15934937
references.citation: Brain Res. 1998 Jul 6;798(1-2):1-6
references.pmid: 9666056
references.citation: J Comp Neurol. 1987 Jul 22;261(4):562-82
references.pmid: 2440918
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):417-20
references.pmid: 19159918
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6169-73
references.pmid: 12721372
references.citation: Nature. 1978 Nov 9;276(5684):186-8
references.pmid: 216919
references.citation: Dialogues Clin Neurosci. 2006;8(4):383-95
references.pmid: 17290797
references.citation: Neuropsychopharmacology. 2007 Aug;32(8):1840-54
references.pmid: 17203014
references.citation: Cell Mol Life Sci. 2008 Jun;65(12):1826-35
references.pmid: 18500643
references.citation: CNS Neurol Disord Drug Targets. 2006 Apr;5(2):225-32
references.pmid: 16611095
references.citation: Brain Res. 1993 Oct 8;624(1-2):188-98
references.pmid: 8252391
references.citation: Regul Pept. 2005 Feb 15;125(1-3):67-78
references.pmid: 15582716
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9028-33
references.pmid: 12853567
references.citation: Alcohol Clin Exp Res. 2004 Dec;28(12):1822-8
references.pmid: 15608598
references.citation: J Neurosci. 1999 Sep 1;19(17):7375-83
references.pmid: 10460244
references.citation: Science. 2006 Feb 17;311(5763):1017-20
references.pmid: 16484499
references.citation: J Neurochem. 2007 May;101(4):1060-71
references.pmid: 17286593
references.citation: Brain Res. 2003 Nov 21;991(1-2):206-11
references.pmid: 14575893
references.citation: J Neurochem. 2002 Oct;83(2):442-51
references.pmid: 12423254
references.citation: Neuroscience. 1998 Nov;87(1):79-94
references.pmid: 9722143
references.citation: Ann N Y Acad Sci. 1999 Jun 29;877:486-98
references.pmid: 10415666
references.citation: J Neurochem. 2001 Jan;76(1):191-200
references.pmid: 11145992
references.citation: Brain Res Rev. 2008 Aug;58(2):415-52
references.pmid: 18222544
references.citation: J Comp Neurol. 1999 Jul 5;409(3):469-81
references.pmid: 10379831
references.citation: Cell Mol Life Sci. 2008 Jun;65(12):1820-5
references.pmid: 18500644
references.citation: J Comp Neurol. 2004 Nov 22;479(4):410-23
references.pmid: 15514977
references.citation: Neuropsychopharmacology. 2003 Jun;28(6):1031-44
references.pmid: 12700679
references.citation: Neuropeptides. 2005 Jun;39(3):299-304
references.pmid: 15944026
references.citation: Brain Res Mol Brain Res. 1995 Dec 28;34(2):179-89
references.pmid: 8750821
references.citation: Neuropeptides. 2005 Jun;39(3):281-7
references.pmid: 15944023
references.citation: Neurosci Biobehav Rev. 2008 Oct;32(8):1485-93
references.pmid: 18632153
references.citation: Eur J Pharmacol. 1993 Jan 12;230(2):223-30
references.pmid: 7678551
references.citation: Mol Psychiatry. 2006 Mar;11(3):301-11
references.pmid: 16314872
references.citation: Neurochem Res. 2008 Feb;33(2):285-91
references.pmid: 17973188
references.citation: Neuroscience. 2005;133(2):591-604
references.pmid: 15885916
references.citation: Neuroscience. 2007 Nov 30;150(1):8-13
references.pmid: 17961928
references.citation: Neuropharmacology. 2009;56 Suppl 1:18-31
references.pmid: 18725236
references.citation: Mol Pharmacol. 1997 Sep;52(3):337-43
references.pmid: 9281594
references.citation: Cell Mol Life Sci. 2008 Jun;65(12):1793-5
references.pmid: 18500648
references.citation: Brain Res. 2001 Nov 16;919(1):169-74
references.pmid: 11689176
references.citation: Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17489-94
references.pmid: 16287967
references.citation: Pharmacol Ther. 2007 Aug;115(2):177-207
references.pmid: 17604107
references.citation: Brain Res. 2008 Jan 29;1191:63-8
references.pmid: 18096145
references.citation: J Neurosci Methods. 2001 Aug 15;109(1):71-80
references.pmid: 11489302
references.citation: J Neurosci. 2000 Aug 15;20(16):6276-81
references.pmid: 10934278
references.citation: Neuroreport. 2001 Jun 13;12(8):1779-82
references.pmid: 11409758
references.citation: Pharmacol Rev. 1991 Dec;43(4):425-73
references.pmid: 1775506
references.citation: Eur J Pharmacol. 1993 Sep 21;242(1):59-64
references.pmid: 7693496
references.citation: Biochemistry. 1998 May 12;37(19):6711-7
references.pmid: 9578554
references.citation: Neuropsychopharmacology. 2008 Jul;33(8):1864-73
references.pmid: 17957220
references.citation: Neuropeptides. 1994 Jan;26(1):65-9
references.pmid: 7512699
references.citation: Trends Pharmacol Sci. 1992 May;13(5):177-84
references.pmid: 1604710
references.citation: Endocrinology. 1990 Nov;127(5):2281-9
references.pmid: 1699744
references.citation: Am J Hypertens. 1998 Dec;11(12):1475-9
references.pmid: 9880130
references.citation: Neurosci Biobehav Rev. 2006;30(2):203-14
references.pmid: 16157378
references.citation: Annu Rev Pharmacol Toxicol. 1988;28:285-310
references.pmid: 2898236
references.citation: J Neurosci. 1990 Jul;10(7):2308-17
references.pmid: 2115910
references.citation: Trends Neurosci. 1992 May;15(5):186-91
references.pmid: 1377426
references.citation: J Neurochem. 1988 Dec;51(6):1953-5
references.pmid: 2460591
references.citation: Cell Mol Life Sci. 2008 Jun;65(12):1836-41
references.pmid: 18500642
references.citation: J Mol Neurosci. 1995;6(1):33-41
references.pmid: 8562318
references.citation: Neurosci Lett. 1996 Jul 5;212(1):21-4
references.pmid: 8823753
references.citation: Cell Mol Life Sci. 2008 Jun;65(12):1806-12
references.pmid: 18500646
references.citation: Cell Mol Life Sci. 2008 Jun;65(12):1864-71
references.pmid: 18500639
references.citation: J Neurosci. 1986 Dec;6(12):3640-54
references.pmid: 2432203
references.citation: Neurosci Lett. 2002 Jan 11;317(2):101-5
references.pmid: 11755250
references.citation: Peptides. 2004 Mar;25(3):433-64
references.pmid: 15134866
references.citation: Behav Brain Res. 1999 Jun;101(2):129-52
references.pmid: 10372570
references.citation: Science. 1981 Nov 6;214(4521):685-7
references.pmid: 7292008
references.citation: Neuron. 1993 Jul;11(1):93-104
references.pmid: 8393324
references.citation: Prog Brain Res. 2008;172:7-44
references.pmid: 18772026